Clinical trial
Study to Reduce Intravenous Exposures (STRIVE)
NCT00391482 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00391482 |
|---|---|
| Title | Study to Reduce Intravenous Exposures (STRIVE) |
| Official title | Behavioral Intervention Trial to Reduce Transmission Risks and Improve HCV Treatment Access Among HCV-infected Injection Drug Users |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C, HIV Infections |
| Intervention type | Behavioral |
| Interventions | Peer Mentoring Intervention for HCV-Infected IDUs |
| Enrollment | 750 |
| Start date | Jun 1, 2002 |
| Completion | Feb 1, 2005 |
| First posted | Oct 24, 2006 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: